Dicyclohexylcarbodiimide → HCID 86688936, compound
Reaction equation
Cl.[N:2]1([CH:8]([C:12]2[CH:17]=[CH:16][C:15]([CH3:18])=[CH:14][CH:13]=2)[C:9]([OH:11])=[O:10])[CH2:7][CH2:6][CH2:5][CH2:4][CH2:3]1.C1CCC(N=C=NC2CCCCC2)CC1.C1C=CC2N(O)N=NC=2C=1.[N:44]12[CH2:51][CH2:50][CH:47]([CH2:48][CH2:49]1)[C@@H:46](O)[CH2:45]2>C1COCC1>[N:2]1([CH:8]([C:12]2[CH:17]=[CH:16][C:15]([CH3:18])=[CH:14][CH:13]=2)[C:9]([O:11][C@@H:46]2[CH:47]3[CH2:50][CH2:51][N:44]([CH2:49][CH2:48]3)[CH2:45]2)=[O:10])[CH2:3][CH2:4][CH2:5][CH2:6][CH2:7]1Participants
6
Procedure
2-(Piperidin-1-yl)-2-p-tolylacetic acid hydrochloride (242 mg, 0.90 mmol), DCC (370 mg, 1.79 mmol) and HOBT (275 mg, 1.79 mmol) were dissolved in dry THF (10 ml). (R)-quinuclidin-3-ol (342 mg, 2.69 mmol) was added and the mixture was stirred at room temperature for 16 hours. THF was evaporated and the residue was taken up with EtOAc and washed with sat. NaHCO3, water and brine. The organic layer was recovered, dried over Na2SO4, filtered and evaporated. The crude was purified by flash chromatography (DCM/MeOH=9/1) to obtain (R)-quinuclidin-3-yl 2-(piperidin-1-yl)-2-p-tolylacetate (169 mg, 55% yield) as a colourless oil.
Workup
- customTHF was evaporated
- washwashed with sat. NaHCO3, water and brine
- customThe organic layer was recovered
- dry with materialdried over Na2SO4
- filtrationfiltered
- customevaporated
- customThe crude was purified by flash chromatography (DCM/MeOH=9/1)
Sources & evidence
- ORD record
- ord-f9714fb48c7d4c2b9e1f6e50e226c22b
- Source dataset
- uspto-grants-2014_06
- Patent number
- US08748613B2
Reaction notes
Loading…